Risk of mortality among individual antipsychotics in patients with dementia - Wikidata - wikimedia - TriplyDB

Risk of mortality among individual antipsychotics in patients with dementia

Risk of mortality among individual antipsychotics in patients with dementia

http://www.wikidata.org/entity/Q34634590

about

Behavioral and psychological symptoms of dementia Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders Pharmacological management of behavioral symptoms associated with dementia Assessment and management of behavioral and psychological symptoms of dementia Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia.The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease Psychiatric Aspects of Dementia.Psychotropic drug use and mortality in old people with dementia: investigating sex differences.Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study.What is known about dementia care recipient violence and aggression against caregivers?Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea.Pharmacotherapy of neuropsychiatric symptoms of dementia Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD).Quetiapine safety in older adults: a systematic literature review.The impact of dementia on drug costs in older people: results from the SNAC study Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial Atypical antipsychotic use in patients with dementia: managing safety concerns.Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based study Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study.Pharmacotherapeutic management of dementia across settings of care.Drug Therapy for Behavioral and Psychological Symptoms of Dementia Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults.Pharmacogenetics of clinical response to risperidone.A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.Quality of psychopharmacological medication prescribing and mortality in Medicare beneficiaries in nursing homes.End-of-life care in advanced dementia.Delirium superimposed on dementia and mild cognitive impairment.Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population.Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review.

P2860

Q21129432-34C8649B-A8DC-4071-830F-6CF8D2189578 Q26773524-FFE5E2E5-83EF-4613-98F0-295D466B6F10 Q27009995-C90AE6A2-23A0-4F88-B0C3-E76DC0B8D6B4 Q28081955-CCC555A1-DB77-4212-B558-847D582CDFAC Q28088782-F4C48EEA-C657-4BD4-B72C-B94C5699AFCD Q30401309-58E760A0-C4B1-4CEA-8BDE-2F577CBA1E17 Q30413790-9B5920D7-1926-4A72-93D5-F58967380412 Q33562417-1F43FD1D-3E06-4C2F-8DAC-5299B47C463B Q33729950-3F50C3FC-8D01-44E2-8555-3A7BD5ED2E31 Q33736204-E383F625-0052-4F8B-BCA3-F8E625716CA5 Q33831536-BBBCA517-2FA3-419F-B327-F84291DFEB70 Q33844380-BA22471C-0526-42DB-92D9-DA7DC2A80965 Q34070862-2A869EB6-071A-40D5-812A-4D5A6DF2E5B8 Q34438066-09DAE730-429E-4FC6-8185-4117CAD718C5 Q35185368-3C1B74D7-F9F6-4DE4-81F5-1F93CD0673AB Q35196617-ACCDD1E8-F459-43EC-9168-357F41678406 Q35229781-57D193EA-413C-4413-BFD1-DE10731C9D9E Q35630897-B22304D0-8967-4726-B2C2-66C33A24DCC1 Q35848943-8A704D4C-2D34-439A-93D5-FC20D0C5FD75 Q35905294-BEA94317-1D61-461E-AA1A-78766BE6F4A4 Q35938803-70FC1EF0-EFE4-4A48-91A2-209D6F010E4C Q35944999-51B510EB-07D5-4598-857B-CD39185E585D Q36345261-D584453B-735E-4A6D-B5BE-2642DCF14BF4 Q36450333-30A4F10D-7037-4B1F-962C-10FFF5D4F248 Q36670523-ABDE8F70-A1C5-4376-844A-25425115C802 Q36706808-9D8DF2C1-7465-4C6A-AF51-9B08785172CB Q36849968-A4EEC364-4102-4EA8-9608-2C76E8035C80 Q36925888-6A19B50E-DD38-436F-9301-9FD455DE92BB Q37196381-98F7BC2D-724B-4505-A946-54FF65C45CDE Q37505818-D49D342C-E1BE-47DA-9BDC-32F618CC350C Q37693772-F3628727-F8CC-45C3-A19E-FC4DF776B337 Q37696596-C5F732C7-B2A2-4F05-8393-3FFAA4D44602 Q38074712-D519366B-7185-485B-824B-62AB90F9E5C1 Q38150568-1A23224E-5557-44B3-8D0B-9216DDBA27F5 Q38214498-8CF113E5-E144-4F75-88D4-BC24F0238B94 Q38231604-B4558202-5C6E-42A9-A28D-F67309D41455 Q38270209-90364C3B-C4E9-4B77-90D6-576D72255CC4 Q38270211-E6370D25-659D-4DF3-9595-65F340B2D671 Q38402884-51794F91-1D44-4841-A958-53C4F4061BF1 Q38646167-AC5302D9-457A-4D87-99E4-EA619AF72E17

P2860

Risk of mortality among individual antipsychotics in patients with dementia

http://www.wikidata.org/entity/Q34634590

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Risk of mortality among individual antipsychotics in patients with dementia

@ast

Risk of mortality among individual antipsychotics in patients with dementia

@en

Risk of mortality among individual antipsychotics in patients with dementia

@nl

type

label

Risk of mortality among individual antipsychotics in patients with dementia

@ast

Risk of mortality among individual antipsychotics in patients with dementia

@en

Risk of mortality among individual antipsychotics in patients with dementia

@nl

prefLabel

Risk of mortality among individual antipsychotics in patients with dementia

@ast

Risk of mortality among individual antipsychotics in patients with dementia

@en

Risk of mortality among individual antipsychotics in patients with dementia

@nl

P1433

Q34634590-EA93A002-FFA9-4685-97C4-A4C520E6EF2E

P1476

Q34634590-3C92C6EB-E741-4679-A667-77FE2C07B862

P2093

Q34634590-00C270E3-7028-4A01-B998-7550FEC6F00D

Q34634590-0198CF6A-886F-40D9-9703-FA84092E1409

Q34634590-1569BFA5-E47A-48F2-B85E-D0D97AD6396E

Q34634590-360F6FEC-0C0C-4290-B1F4-7A18EA388FCD

Q34634590-5CC06458-6ED1-45FA-A721-A63291868E2A

Q34634590-8179DE2F-0553-4C15-B4D1-E3AAE5C3C8C0

Q34634590-82EC6922-4413-469E-9968-36B9AB749757

Q34634590-A03FFF4C-07C2-4FDB-954B-BC2E8698A79A

P2860

Q34634590-07F66DA3-2CC7-4652-8A6A-3DC751F49CF6

Q34634590-0BCAE748-3ADA-40B1-8908-6AEF92C3A30E

Q34634590-12B1C608-1AEB-41EC-A659-4173F8F001B0

Q34634590-15275EA4-263F-466A-80BE-857B5AD89E8D

Q34634590-1F6B06DC-EF9F-4987-8F3B-915578B13394

Q34634590-2FFFC5B9-DB64-407C-97A8-B13AD725C466

Q34634590-322BA3FA-BA0C-4C50-944E-182508619780

Q34634590-3DB6218C-8D42-40E2-9F2E-CE3246678174

Q34634590-5D442B78-6B7E-4D6D-9A68-F82FCABFA05B

Q34634590-748FF42F-7608-4CB0-9053-896C766B2583

P304

Q34634590-17C4777B-1CCA-4602-839E-D5C57EC63AF7

P31

Q34634590-612FE14C-D910-4D4E-AEDA-C2FFE7B4734D

P356

Q34634590-A845D70E-E7D1-455E-8E17-88F0FF0C2640

P407

Q34634590-1A317808-AC3D-4E28-B6BC-61D14FD274A5

P433

Q34634590-5CB9CEC7-99AE-4BDB-AD07-E4ABF027128E

P478

Q34634590-6824CBF1-F71A-4B9E-B2FB-8C6385B0DE3D

P50

Q34634590-D5E9E32D-3424-48A6-96FF-44DE4A6D9358

P577

Q34634590-CA214BA8-2437-447F-8AC4-EA245F2ED6EE

P5875

Q34634590-AA61DC44-069C-4AE1-A4DC-272F19EA472C

P698

Q34634590-37752FC3-ABC9-404D-B6C5-76C742500122

P921

Q34634590-D28314A7-2681-4795-80A6-1AFFB96ED2F7

P932

Q34634590-47E6C67D-DEA4-4E6E-98FB-81DC47CDA0B8

P356

APPI.AJP.2011.11030347

P1433

American Journal of Psychiatry

P1476

Risk of mortality among individual antipsychotics in patients with dementia

@en

P2093

Claire Chiang

http://www.w3.org/2001/XMLSchema#string

Francesca Cunningham

http://www.w3.org/2001/XMLSchema#string

Frederic C Blow

http://www.w3.org/2001/XMLSchema#string

Helen C Kales

http://www.w3.org/2001/XMLSchema#string

Hyungjin Myra Kim

http://www.w3.org/2001/XMLSchema#string

Kara Zivin

http://www.w3.org/2001/XMLSchema#string

Lisa S Seyfried

http://www.w3.org/2001/XMLSchema#string

Lon S Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Placebo-controlled study of divalproex sodium for agitation in dementia.

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data.

Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

Antipsychotic drug use and mortality in older adults with dementia.

Prevalence of dementia in the United States: the aging, demographics, and memory study.

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

P304

71-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.2011.11030347

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

Marcia Valenstein

P577

2011-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51919707

http://www.w3.org/2001/XMLSchema#string

P698

22193526

http://www.w3.org/2001/XMLSchema#string

P921

P932

4269551

http://www.w3.org/2001/XMLSchema#string